Pegunigalsidase alfa Uses, Dosage, Side Effects and more
Pegunigalsidase alfa is under investigation in clinical trial NCT02921620 (Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease).
| Trade Name | Pegunigalsidase alfa |
| Generic | Pegunigalsidase alfa |
| Pegunigalsidase alfa Other Names | Pegunigalsidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
